209 related articles for article (PubMed ID: 23269996)
21. The impact of integration on outpatient chemotherapy use and spending in Medicare.
Jung J; Feldman R; Kalidindi Y
Health Econ; 2019 Apr; 28(4):517-528. PubMed ID: 30695812
[TBL] [Abstract][Full Text] [Related]
22. Operating on commission: analyzing how physician financial incentives affect surgery rates.
Shafrin J
Health Econ; 2010 May; 19(5):562-80. PubMed ID: 19399752
[TBL] [Abstract][Full Text] [Related]
23. Differences in hospice referrals.
VanAlstine N
Nurse Pract; 2003 Oct; 28(10):6; discussion 6. PubMed ID: 14560124
[No Abstract] [Full Text] [Related]
24. The impact of physician economic incentives on admission rates of patients with ambulatory sensitive conditions: an analysis comparing two managed care structures and indemnity insurance.
Josephson GW; Karcz A
Am J Manag Care; 1997 Jan; 3(1):49-56. PubMed ID: 10169249
[TBL] [Abstract][Full Text] [Related]
25. The effect of financial incentives on the quality of health care provided by primary care physicians.
Scott A; Sivey P; Ait Ouakrim D; Willenberg L; Naccarella L; Furler J; Young D
Cochrane Database Syst Rev; 2011 Sep; (9):CD008451. PubMed ID: 21901722
[TBL] [Abstract][Full Text] [Related]
26. Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer.
Jagsi R; Ward KC; Abrahamse PH; Wallner LP; Kurian AW; Hamilton AS; Katz SJ; Hawley ST
Cancer; 2018 Sep; 124(18):3668-3676. PubMed ID: 30033631
[TBL] [Abstract][Full Text] [Related]
27. Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
Gori S; Di Maio M; Pinto C; Alabiso O; Baldini E; Barbato E; Beretta GD; Bravi S; Caffo O; Canobbio L; Carrozza F; Cinieri S; Cruciani G; Dinota A; Gebbia V; Giustini L; Graiff C; Molino A; Muggiano A; Pandoli G; Puglisi F; Tagliaferri P; Tomao S; Lunardi G; Venturini M;
Tumori; 2013; 99(1):35-8. PubMed ID: 23548997
[TBL] [Abstract][Full Text] [Related]
28. Oncologists' Perceptions of Drug Affordability Using NCCN Evidence Blocks: Results from a National Survey.
Shah-Manek B; Wong W; Ravelo A; DiBonaventura M
J Manag Care Spec Pharm; 2018 Jun; 24(6):565-571. PubMed ID: 29451078
[TBL] [Abstract][Full Text] [Related]
29. An analysis of alternative funding for physicians practicing gynecologic oncology in Ontario, Canada prior to 2001.
Elit L
Eur J Gynaecol Oncol; 2006; 27(1):61-4. PubMed ID: 16550972
[TBL] [Abstract][Full Text] [Related]
30. Oncologists and primary care physicians' attitudes toward pain control and morphine prescribing in France.
Larue F; Colleau SM; Fontaine A; Brasseur L
Cancer; 1995 Dec; 76(11):2375-82. PubMed ID: 8635046
[TBL] [Abstract][Full Text] [Related]
31. Type of contract and supplier-induced demand for primary physicians in Norway.
Grytten J; Sørensen R
J Health Econ; 2001 May; 20(3):379-93. PubMed ID: 11373837
[TBL] [Abstract][Full Text] [Related]
32. The effect of explicit financial incentives on physician behavior.
Armour BS; Pitts MM; Maclean R; Cangialose C; Kishel M; Imai H; Etchason J
Arch Intern Med; 2001 May; 161(10):1261-6. PubMed ID: 11371253
[TBL] [Abstract][Full Text] [Related]
33. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
Schrag D; Hanger M
J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
[TBL] [Abstract][Full Text] [Related]
34. Financial incentives.
Silver SE
Ann Intern Med; 1990 Nov; 113(10):808-9. PubMed ID: 2240892
[No Abstract] [Full Text] [Related]
35. The impact of financial incentives on physician behavior in managed care plans: a review of the evidence.
Hellinger FJ
Med Care Res Rev; 1996 Sep; 53(3):294-314. PubMed ID: 10159930
[No Abstract] [Full Text] [Related]
36. The relationship between method of physician payment and patient trust.
Kao AC; Green DC; Zaslavsky AM; Koplan JP; Cleary PD
JAMA; 1998 Nov; 280(19):1708-14. PubMed ID: 9832007
[TBL] [Abstract][Full Text] [Related]
37. Impact of physician income source on productivity.
Baerlocher MO; Noble J; Detsky AS
Clin Invest Med; 2007; 30(1):42-3. PubMed ID: 17716539
[TBL] [Abstract][Full Text] [Related]
38. Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care.
O'Neil B; Graves AJ; Barocas DA; Chang SS; Penson DF; Resnick MJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26582063
[TBL] [Abstract][Full Text] [Related]
39. The effect of explicit financial incentives on physician behavior.
Gupta R; Gupta S
Arch Intern Med; 2002 Mar; 162(5):612-3. PubMed ID: 11871940
[No Abstract] [Full Text] [Related]
40. Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.
Mitchell AP; Winn AN; Lund JL; Dusetzina SB
Oncologist; 2019 May; 24(5):632-639. PubMed ID: 30728276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
